Additional file 1: of Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer

Table S1. Drug classification. The table shows the drug classification used for the analysis, grouping drugs into targeted therapy, chemotherapy, hormone therapy and immunotherapy. Abbreviations: cbx6 Chromobox 6, CDK4 Cyclin-dependent kinase 4, CDK6 Cyclin-dependent kinase 6, EGFR Epidermal growth factor receptor, Her2 Human epidermal growth factor receptor 2, mTOR Mechanistic target of rapamycin, PD-L1 Programmed cell death 1 ligand 1, VEGF Vascular endothelial growth factor. (XLSX 10 kb)